Skip to content
Menu

Akebia Therapeutics, Inc. AKBA

Full chart Compare
Set alert

Price alert · AKBA

All alert types
0.39 USD -0.04 (-8.71%)

Regular-session close

0.40 +0.01 +3.50%

After hours · Nov 20, 7:50 PM ET

0.3849 Day range 0.4331
0.361 52-week range 1.73
YTD
-76.06%
1 year
-74.97%

Revenue & Expenses

Revenue Profit Costs
Gross Profit$196.73MNet Loss$5.34MCost of Revenue$39.46MExpenses$202.08MSelling, General & Admin$107.48MResearch & Development$62.36MOther Operating Expenses$3.40MInterest Expense$24.18MOther Expenses$3.04MIncome Tax$1.62MRevenue$236.20M

Latest period ending Dec 31, 2025 · select a line to chart its full history

AKBA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
236.20M160.18M194.62M292.48M211.65M
196.73M97.00M120.47M206.92M60.98M
26.89M-47.25M-43.02M-77.60M-264.50M
-5.34M-69.41M-51.92M-94.23M-282.02M
-0.02-0.33-0.28-0.52-1.70
AKBA annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
184.84M51.87M42.92M90.47M149.80M
376.56M220.67M241.70M356.05M529.35M
343.95M269.86M272.29M350.82M455.34M
48.25M42.24M43.63M152.52M131.25M
32.61M-49.19M-30.58M5.23M74.01M
AKBA annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
67.99M-40.66M-23.38M-73.15M-252.97M
-7.93M-33.00K0-114.00K39.94M
72.93M49.66M-25.21M14.60M133.73M
132.99M8.97M-48.59M-58.67M-79.29M